Moderate mitral regurgitation in patients undergoing CABG--the MoMIC trial

Per Wierup1, Henrik Egeblad, Sten Lyager Nielsen

  • 1Department of Cardiothoracic Surgery, Aarhus University Hospital, Skejby, Aarhus, Denmark. pwi@sks.aaa.dk

Insights

For patients undergoing coronary artery bypass grafting (CABG), the Moderate Mitral Regurgitation In Patients Undergoing CABG (MoMIC) trial investigates if correcting moderate ischemic mitral regurgitation (IMR) improves survival. Results will guide treatment decisions for this common condition.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Trials

Background:

  • Moderate ischemic mitral regurgitation (IMR) is linked to poor long-term survival and heart failure hospitalizations.
  • Current practice often omits mitral valve repair in CABG patients with moderate IMR.
  • Lack of robust data necessitates a large-scale trial to inform clinical decision-making.

Purpose of the Study:

  • To determine if mitral valve correction alongside CABG improves outcomes in patients with moderate IMR.
  • To provide evidence-based guidance for managing moderate IMR during CABG surgery.

Main Methods:

  • The Moderate Mitral Regurgitation In Patients Undergoing CABG (MoMIC) trial is an international, multi-center study.
  • 550 patients with moderate IMR undergoing CABG will be randomized.
  • Comparison of CABG alone versus CABG plus mitral valve correction.
  • Primary endpoint: composite of mortality and heart failure rehospitalization at five years.

Main Results:

  • Patient enrollment and randomization commenced in February 2008.
  • The study is designed to provide definitive data on the efficacy of mitral valve correction in this population.

Conclusions:

  • Findings will clarify whether mitral valve correction is a superior strategy for moderate IMR in CABG patients.
  • If proven beneficial, the results are expected to influence clinical practice guidelines.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...